Societal and Family Lifetime Cost of Dementia: Implications for Policy
- PMID: 28815557
- PMCID: PMC5657516
- DOI: 10.1111/jgs.15043
Societal and Family Lifetime Cost of Dementia: Implications for Policy
Abstract
Objectives: To estimate the cost of dementia and the extra cost of caring for someone with dementia over the cost of caring for someone without dementia.
Design: We developed an evidence-based mathematical model to simulate disease progression for newly diagnosed individuals with dementia. Data-driven trajectories of cognition, function, and behavioral and psychological symptoms were used to model disease progression and predict costs. Using modeling, we evaluated lifetime and annual costs of individuals with dementia, compared costs of those with and without clinical features of dementia, and evaluated the effect of reducing functional decline or behavioral and psychological symptoms by 10% for 12 months (implemented when Mini-Mental State Examination score ≤21).
Setting: Mathematical model.
Participants: Representative simulated U.S. incident dementia cases.
Measurements: Value of informal care, out-of-pocket expenditures, Medicaid expenditures, and Medicare expenditures.
Results: From time of diagnosis (mean age 83), discounted total lifetime cost of care for a person with dementia was $321,780 (2015 dollars). Families incurred 70% of the total cost burden ($225,140), Medicaid accounted for 14% ($44,090), and Medicare accounted for 16% ($52,540). Costs for a person with dementia over a lifetime were $184,500 greater (86% incurred by families) than for someone without dementia. Total annual cost peaked at $89,000, and net cost peaked at $72,400. Reducing functional decline or behavioral and psychological symptoms by 10% resulted in $3,880 and $680 lower lifetime costs than natural disease progression.
Conclusion: Dementia substantially increases lifetime costs of care. Long-lasting, effective interventions are needed to support families because they incur the most dementia cost.
Keywords: dementia; dementia cost; family caregiving; institutionalization.
© 2017, Copyright the Authors Journal compilation © 2017, The American Geriatrics Society.
Conflict of interest statement
Figures
Similar articles
-
Residential Setting and the Cumulative Financial Burden of Dementia in the 7 Years Before Death.J Am Geriatr Soc. 2020 Jun;68(6):1319-1324. doi: 10.1111/jgs.16414. Epub 2020 Mar 18. J Am Geriatr Soc. 2020. PMID: 32187655 Free PMC article.
-
A longitudinal analysis of the lifetime cost of dementia.Health Serv Res. 2012 Aug;47(4):1660-78. doi: 10.1111/j.1475-6773.2011.01365.x. Epub 2011 Dec 15. Health Serv Res. 2012. PMID: 22171532 Free PMC article.
-
The burden of health care costs for patients with dementia in the last 5 years of life.Ann Intern Med. 2015 Nov 17;163(10):729-36. doi: 10.7326/M15-0381. Epub 2015 Oct 27. Ann Intern Med. 2015. PMID: 26502320 Free PMC article.
-
[The economical impact of dementia].Presse Med. 2005 Jan 15;34(1):35-41. doi: 10.1016/s0755-4982(05)83882-5. Presse Med. 2005. PMID: 15685097 Review. French.
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
Cited by
-
Prevalence of Geriatric Syndromes among Older Outpatients with Dementia.Dement Geriatr Cogn Dis Extra. 2024 Sep 2;14(1):89-95. doi: 10.1159/000541237. eCollection 2024 Jan-Dec. Dement Geriatr Cogn Dis Extra. 2024. PMID: 39473812 Free PMC article.
-
Long-term cognitive training enhances fluid cognition and brain connectivity in individuals with MCI.Transl Psychiatry. 2024 Oct 23;14(1):447. doi: 10.1038/s41398-024-03153-x. Transl Psychiatry. 2024. PMID: 39443463 Free PMC article. Clinical Trial.
-
The COM-B model: a cross-sectional survey assessing capability, opportunities, and motivation to follow the MIND diet among informal female caregivers of people with Alzheimer's disease and related dementias.Front Dement. 2024 Oct 3;3:1451310. doi: 10.3389/frdem.2024.1451310. eCollection 2024. Front Dement. 2024. PMID: 39421465 Free PMC article.
-
Ascertaining Out-of-Pocket Costs of Dementia Care: Feasibility Study of a Web-Based Weekly Survey.JMIR Form Res. 2024 Sep 25;8:e56878. doi: 10.2196/56878. JMIR Form Res. 2024. PMID: 39321453 Free PMC article.
-
The Evolving Use of Gold Nanoparticles as a Possible Reversal Agent for the Symptoms of Neurodegenerative Diseases: A Narrative Review.Cureus. 2024 Jul 18;16(7):e64846. doi: 10.7759/cureus.64846. eCollection 2024 Jul. Cureus. 2024. PMID: 39156432 Free PMC article. Review.
References
-
- Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12(4):459–509. - PubMed
-
- US Department of Health and Human Services. National Plan to Address Alzheimer’s Disease: 2016 Update. ( https://aspe.hhs.gov/system/files/pdf/205581/NatlPlan2016.pdf)
-
- Langa KM, Plassman BL, Wallace RB, et al. The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology. 2005;25(4):181–191. - PubMed
MeSH terms
Grants and funding
- P30 AG013854/AG/NIA NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- P50 AG047266/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- P50 AG047366/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- P50 AG033514/AG/NIA NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- R36 HS024165/HS/AHRQ HHS/United States
- P50 AG005142/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- U01 AG009740/AG/NIA NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- P50 AG047270/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- P50 AG016570/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
